GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 1 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $124,000 | +21.6% | 1,970 | -1.5% | 0.01% | +16.7% |
| Q1 2020 | $102,000 | -35.8% | 2,000 | 0.0% | 0.01% | -14.3% |
| Q4 2019 | $159,000 | +63.9% | 2,000 | 0.0% | 0.01% | +133.3% |
| Q3 2019 | $97,000 | +10.2% | 2,000 | +19.0% | 0.00% | 0.0% |
| Q2 2019 | $88,000 | -1.1% | 1,680 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $89,000 | -55.5% | 1,680 | -65.4% | 0.00% | -57.1% |
| Q4 2018 | $200,000 | +8.1% | 4,860 | 0.0% | 0.01% | +40.0% |
| Q3 2018 | $185,000 | -12.3% | 4,860 | +4.3% | 0.01% | -16.7% |
| Q2 2018 | $211,000 | -4.1% | 4,660 | +2.2% | 0.01% | -14.3% |
| Q1 2018 | $220,000 | – | 4,560 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alerce Investment Management, L.P. | 356,270 | $24,262,000 | 23.36% |
| Twin Securities, Inc. | 376,669 | $25,651,000 | 11.94% |
| Paradigm Biocapital Advisors LP | 1,175,879 | $80,077,000 | 10.68% |
| Chicago Capital Management, LLC | 246,246 | $16,769,000 | 9.12% |
| HARVEST MANAGEMENT LLC | 141,500 | $9,636,000 | 7.78% |
| Fernwood Investment Management, LLC | 174,724 | $11,899,000 | 5.02% |
| ArchPoint Investors | 168,725 | $11,490,000 | 4.69% |
| HAVENS ADVISORS LLC | 46,000 | $3,133,000 | 4.69% |
| Perceptive Advisors | 2,322,247 | $158,145,000 | 4.59% |
| Crabel Capital Management, LLC | 112,680 | $7,674,000 | 4.48% |